Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02206061 · ClinicalTrials.gov registry record · NA
School-based Asthma Care for Teens (SB-ACT)
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 430
- Enrollment target
NCT02206061 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 430 participants.
The verdict
NCT02206061, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 430 participants
- Enrollment target
Study Summary
The goal of this study is to evaluate the widespread implementation of a developmentally appropriate preventive asthma care intervention for urban teens. The School Based Asthma Care for Teens (SB-ACT) program includes two core components: 1) a trial of directly observed therapy (DOT) to allow the teen to experience the potential benefits from adhering to guideline-based asthma treatment, and 2) a developmentally appropriate Motivational Interviewing (MI) Counseling Intervention to help the teen transition to independent long-term medication adherence. The investigators hypothesize that teens receiving the SB-ACT program will 1) experience less asthma-related morbidity than an asthma education (AE) attention-control comparison group, and 2) have improved adherence, less urgent healthcare use, less absenteeism, improved quality of life, and reduced FeNO compared to AE. The investigators also hypothesize that participants receiving DOT-only will have improved asthma-related outcomes immediately following their DOT trial vs. teens receiving AE, but will not have sustained, clinically significant improvement in outcomes once the DOT phase is complete. This represents a unique opportunity to build upon existing community relationships with an innovative and developmentally focused program to improve asthma outcomes for urban teens.
Interventions
- BEHAVIORAL Directly Observed Therapy
- BEHAVIORAL Asthma Education
- BEHAVIORAL School-Based Asthma Care for Teens (SB-ACT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 430 participants |
| Start Date | 2014-07 |
| Est. Completion | 2021-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02206061
The ClinicalTrials.gov registry entry for NCT02206061 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 430 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Directly Observed Therapy is the first listed.
NCT02206061 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02206061 about?
NCT02206061 is a clinical study titled "School-based Asthma Care for Teens (SB-ACT)". The goal of this study is to evaluate the widespread implementation of a developmentally appropriate preventive asthma care intervention for urban teens. The School Based Asthma Care for Teens (SB-ACT) program includes two core components: 1) a trial of directly observed therapy (DOT) to allow the t...
What is the current status of trial NCT02206061?
This trial is currently completed. It is a NA study. The enrollment target is 430 participants. The study started on 2014-07. Estimated completion is 2021-02-01.
What interventions are being tested in trial NCT02206061?
The interventions under investigation include: Directly Observed Therapy (BEHAVIORAL), Asthma Education (BEHAVIORAL), School-Based Asthma Care for Teens (SB-ACT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02206061?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.